-+ 0.00%
-+ 0.00%
-+ 0.00%

NextCure Q3 EPS $(1.29) Beats $(1.43) Estimate

Benzinga·11/10/2026 21:19:53
Listen to the news
NextCure (NASDAQ:NXTC) reported quarterly losses of $(1.29) per share which beat the analyst consensus estimate of $(1.43) by 9.79 percent. This is a 59.94 percent increase over losses of $(3.22) per share from the same period last year.